BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 11320105)

  • 1. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels.
    Kenny AM; Prestwood KM; Gruman CA; Marcello KM; Raisz LG
    J Gerontol A Biol Sci Med Sci; 2001 May; 56(5):M266-72. PubMed ID: 11320105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term effects of intramuscular and transdermal testosterone on bone turnover, prostate symptoms, cholesterol, and hematocrit in men over age 70 with low testosterone levels.
    Kenny AM; Prestwood KM; Raisz LG
    Endocr Res; 2000 May; 26(2):153-68. PubMed ID: 10921445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty.
    Kenny AM; Kleppinger A; Annis K; Rathier M; Browner B; Judge JO; McGee D
    J Am Geriatr Soc; 2010 Jun; 58(6):1134-43. PubMed ID: 20722847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of transdermal testosterone on cognitive function and health perception in older men with low bioavailable testosterone levels.
    Kenny AM; Bellantonio S; Gruman CA; Acosta RD; Prestwood KM
    J Gerontol A Biol Sci Med Sci; 2002 May; 57(5):M321-5. PubMed ID: 11983727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body composition and muscle strength in healthy men receiving testosterone enanthate for contraception.
    Young NR; Baker HW; Liu G; Seeman E
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1028-32. PubMed ID: 8408450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men.
    van den Beld AW; de Jong FH; Grobbee DE; Pols HA; Lamberts SW
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3276-82. PubMed ID: 10999822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of bone density in healthy older men with low testosterone levels.
    Kenny AM; Prestwood KM; Marcello KM; Raisz LG
    J Gerontol A Biol Sci Med Sci; 2000 Sep; 55(9):M492-7. PubMed ID: 10995046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal and anthropometric predictors of bone mass in healthy elderly men: major effect of sex hormone binding globulin, parathyroid hormone and body weight.
    Martínez Díaz-Guerra G; Hawkins F; Rapado A; Ruiz Díaz MA; Díaz-Curiel M
    Osteoporos Int; 2001; 12(3):178-84. PubMed ID: 11315235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of chronic endurance exercise to the somatotropic and sex hormone status of older men.
    Cooper CS; Taaffe DR; Guido D; Packer E; Holloway L; Marcus R
    Eur J Endocrinol; 1998 May; 138(5):517-23. PubMed ID: 9625362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy.
    Diamond T; Campbell J; Bryant C; Lynch W
    Cancer; 1998 Oct; 83(8):1561-6. PubMed ID: 9781950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex steroids and bone turnover markers in men with symptomatic vertebral fractures.
    Tuck SP; Scane AC; Fraser WD; Diver MJ; Eastell R; Francis RM
    Bone; 2008 Dec; 43(6):999-1005. PubMed ID: 18817902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Osteogenic Effect of Impact-Loading and Resistance Exercise on Bone Mineral Density in Middle-Aged and Older Men: A Pilot Study.
    Bolam KA; Skinner TL; Jenkins DG; Galvão DA; Taaffe DR
    Gerontology; 2015; 62(1):22-32. PubMed ID: 26226987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy.
    Howell SJ; Radford JA; Adams JE; Smets EM; Warburton R; Shalet SM
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):315-24. PubMed ID: 11589674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels.
    Bhasin S; Storer TW; Asbel-Sethi N; Kilbourne A; Hays R; Sinha-Hikim I; Shen R; Arver S; Beall G
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3155-62. PubMed ID: 9745419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle mass, muscle strength and bone mineral density in postmenopausal women: a cross-sectional study.
    van Geel TA; Geusens PP; Winkens B; Sels JP; Dinant GJ
    Eur J Endocrinol; 2009 Apr; 160(4):681-7. PubMed ID: 19174532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
    Meier C; Woitge HW; Witte K; Lemmer B; Seibel MJ
    J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase of bioavailable testosterone is associated with gain in bone mineral density after cure of primary hyperparathyroidism in postmenopausal women.
    Almqvist EG; Becker C; Bondeson AG; Bondeson L; Svensson J
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):58-62. PubMed ID: 16402929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of vitamin D supplementation during weight loss on sex hormones in postmenopausal women.
    Mason C; De Dieu Tapsoba J; Duggan C; Imayama I; Wang CY; Korde LA; Stanczyk F; McTiernan A
    Menopause; 2016 Jun; 23(6):645-52. PubMed ID: 26859343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.
    Wang C; Cunningham G; Dobs A; Iranmanesh A; Matsumoto AM; Snyder PJ; Weber T; Berman N; Hull L; Swerdloff RS
    J Clin Endocrinol Metab; 2004 May; 89(5):2085-98. PubMed ID: 15126525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study.
    Wang C; Eyre DR; Clark R; Kleinberg D; Newman C; Iranmanesh A; Veldhuis J; Dudley RE; Berman N; Davidson T; Barstow TJ; Sinow R; Alexander G; Swerdloff RS
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3654-62. PubMed ID: 8855818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.